GL
GL
Globe Life Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $1.52B ▲ | $106.35M ▼ | $266M ▼ | 17.45% ▼ | $3.35 ▼ | $379.27M ▼ |
| Q3-2025 | $1.51B ▲ | $147.7M ▲ | $387.84M ▲ | 25.63% ▲ | $4.81 ▲ | $513.24M ▲ |
| Q2-2025 | $1.48B ▲ | $143.18M ▼ | $252.75M ▼ | 17.06% ▼ | $3.09 ▲ | $348.18M ▼ |
| Q1-2025 | $1.48B ▲ | $143.74M ▼ | $254.56M ▼ | 17.2% ▼ | $3.05 ▲ | $351.07M ▲ |
| Q4-2024 | $1.47B | $155.01M | $255.2M | 17.4% | $3.04 | $348.13M |
What's going well?
Revenue is steady, and the company remains profitable. Operating expenses were cut significantly, showing some cost control.
What's concerning?
Gross margins collapsed and profits dropped by nearly a third. Rising product costs and other expenses are eating into earnings, raising questions about future profitability.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $459.42M ▼ | $30.81B ▲ | $24.84B ▲ | $5.97B ▲ |
| Q3-2025 | $18.16B ▲ | $30.53B ▲ | $24.84B ▲ | $5.69B ▲ |
| Q2-2025 | $17.72B ▼ | $29.81B ▲ | $24.39B ▲ | $5.42B ▼ |
| Q1-2025 | $17.87B ▲ | $29.71B ▲ | $24.28B ▲ | $5.43B ▲ |
| Q4-2024 | $17.41B | $29.08B | $23.77B | $5.31B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $266.08M ▲ | $350.6M ▲ | $-265.84M ▼ | $-241.01M ▼ | $-158.01M ▼ | $330.1M ▲ |
| Q3-2025 | $0 | $305.98M ▼ | $-73.79M ▼ | $-171.79M ▲ | $63.59M ▲ | $208.69M ▼ |
| Q2-2025 | $0 ▼ | $307.93M ▼ | $-64.03M ▲ | $-230.78M ▼ | $6.85M ▼ | $294.99M ▼ |
| Q1-2025 | $254.56M ▼ | $431.89M ▲ | $-239.95M ▼ | $-124.46M ▲ | $66.94M ▲ | $420.14M ▲ |
| Q4-2024 | $255.2M | $336.93M | $181.37M | $-500.95M | $30.78M | $321.93M |
What's strong about this company's cash flow?
GL is producing more cash than reported profits, with free cash flow up sharply this quarter. The company is self-funding, buying back shares, and has no reliance on debt.
What are the cash flow concerns?
Cash balance fell this quarter due to heavy buybacks and investments. The company pays no dividends, and the cash cushion, while adequate, is not huge.
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q4-2025 |
|---|---|---|---|---|
Health Segment | $710.00M ▲ | $370.00M ▼ | $380.00M ▲ | $780.00M ▲ |
Life Segment | $1.64Bn ▲ | $830.00M ▼ | $840.00M ▲ | $1.69Bn ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Globe Life Inc.'s financial evolution and strategic trajectory over the past five years.
Globe Life combines a focused market niche with solid, recurring profitability and strong cash generation. Its distribution network—mixing direct‑to‑consumer channels with an extensive captive agency force—gives it broad reach into underserved customer segments. Financially, it benefits from steady revenue growth, robust margins, and high free cash flow that comfortably supports dividends and buybacks. The balance sheet shows a stable asset base and growing retained earnings, while operational initiatives in automation and digital tools reinforce efficiency over time.
Key concerns include rising leverage as debt increases to help fund shareholder returns, a relatively thin short‑term liquidity buffer by simple ratio measures, and some opacity in the reported figures, such as the anomalous disappearance of certain income‑statement lines in the latest year. The customer base is more vulnerable to economic stress, which can affect policy sales and persistency. The company also faces the usual insurance sector challenges—regulatory change, interest‑rate and credit risk, and potential competition from both large incumbents and digital newcomers—without the cushion of a large formal R&D program to drive step‑change innovation.
The overall trajectory appears one of steady, incremental progress rather than dramatic transformation. If Globe Life continues to execute its niche strategy, maintain underwriting discipline, and carefully manage its balance sheet, it seems positioned to sustain solid earnings and cash flow. Future outcomes will hinge on how well it balances generous capital returns with rising leverage, how effectively it deploys technology to keep its distribution advantage, and how resilient its target customers prove to be through economic cycles. Clarifying the recent reporting anomalies and maintaining conservative risk management will be important for sustaining confidence in this otherwise stable profile.
About Globe Life Inc.
https://www.globelifeinsurance.comGlobe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $1.52B ▲ | $106.35M ▼ | $266M ▼ | 17.45% ▼ | $3.35 ▼ | $379.27M ▼ |
| Q3-2025 | $1.51B ▲ | $147.7M ▲ | $387.84M ▲ | 25.63% ▲ | $4.81 ▲ | $513.24M ▲ |
| Q2-2025 | $1.48B ▲ | $143.18M ▼ | $252.75M ▼ | 17.06% ▼ | $3.09 ▲ | $348.18M ▼ |
| Q1-2025 | $1.48B ▲ | $143.74M ▼ | $254.56M ▼ | 17.2% ▼ | $3.05 ▲ | $351.07M ▲ |
| Q4-2024 | $1.47B | $155.01M | $255.2M | 17.4% | $3.04 | $348.13M |
What's going well?
Revenue is steady, and the company remains profitable. Operating expenses were cut significantly, showing some cost control.
What's concerning?
Gross margins collapsed and profits dropped by nearly a third. Rising product costs and other expenses are eating into earnings, raising questions about future profitability.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $459.42M ▼ | $30.81B ▲ | $24.84B ▲ | $5.97B ▲ |
| Q3-2025 | $18.16B ▲ | $30.53B ▲ | $24.84B ▲ | $5.69B ▲ |
| Q2-2025 | $17.72B ▼ | $29.81B ▲ | $24.39B ▲ | $5.42B ▼ |
| Q1-2025 | $17.87B ▲ | $29.71B ▲ | $24.28B ▲ | $5.43B ▲ |
| Q4-2024 | $17.41B | $29.08B | $23.77B | $5.31B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $266.08M ▲ | $350.6M ▲ | $-265.84M ▼ | $-241.01M ▼ | $-158.01M ▼ | $330.1M ▲ |
| Q3-2025 | $0 | $305.98M ▼ | $-73.79M ▼ | $-171.79M ▲ | $63.59M ▲ | $208.69M ▼ |
| Q2-2025 | $0 ▼ | $307.93M ▼ | $-64.03M ▲ | $-230.78M ▼ | $6.85M ▼ | $294.99M ▼ |
| Q1-2025 | $254.56M ▼ | $431.89M ▲ | $-239.95M ▼ | $-124.46M ▲ | $66.94M ▲ | $420.14M ▲ |
| Q4-2024 | $255.2M | $336.93M | $181.37M | $-500.95M | $30.78M | $321.93M |
What's strong about this company's cash flow?
GL is producing more cash than reported profits, with free cash flow up sharply this quarter. The company is self-funding, buying back shares, and has no reliance on debt.
What are the cash flow concerns?
Cash balance fell this quarter due to heavy buybacks and investments. The company pays no dividends, and the cash cushion, while adequate, is not huge.
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q4-2025 |
|---|---|---|---|---|
Health Segment | $710.00M ▲ | $370.00M ▼ | $380.00M ▲ | $780.00M ▲ |
Life Segment | $1.64Bn ▲ | $830.00M ▼ | $840.00M ▲ | $1.69Bn ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Globe Life Inc.'s financial evolution and strategic trajectory over the past five years.
Globe Life combines a focused market niche with solid, recurring profitability and strong cash generation. Its distribution network—mixing direct‑to‑consumer channels with an extensive captive agency force—gives it broad reach into underserved customer segments. Financially, it benefits from steady revenue growth, robust margins, and high free cash flow that comfortably supports dividends and buybacks. The balance sheet shows a stable asset base and growing retained earnings, while operational initiatives in automation and digital tools reinforce efficiency over time.
Key concerns include rising leverage as debt increases to help fund shareholder returns, a relatively thin short‑term liquidity buffer by simple ratio measures, and some opacity in the reported figures, such as the anomalous disappearance of certain income‑statement lines in the latest year. The customer base is more vulnerable to economic stress, which can affect policy sales and persistency. The company also faces the usual insurance sector challenges—regulatory change, interest‑rate and credit risk, and potential competition from both large incumbents and digital newcomers—without the cushion of a large formal R&D program to drive step‑change innovation.
The overall trajectory appears one of steady, incremental progress rather than dramatic transformation. If Globe Life continues to execute its niche strategy, maintain underwriting discipline, and carefully manage its balance sheet, it seems positioned to sustain solid earnings and cash flow. Future outcomes will hinge on how well it balances generous capital returns with rising leverage, how effectively it deploys technology to keep its distribution advantage, and how resilient its target customers prove to be through economic cycles. Clarifying the recent reporting anomalies and maintaining conservative risk management will be important for sustaining confidence in this otherwise stable profile.

CEO
Frank Martin Svoboda
Compensation Summary
(Year 2023)
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2014-07-02 | Forward | 3:2 |
| 2013-05-15 | Reverse | 1:10 |
ETFs Holding This Stock
Summary
Showing Top 3 of 412
Ratings Snapshot
Rating : A
Most Recent Analyst Grades
Wells Fargo
Overweight
Evercore ISI Group
In Line
Truist Securities
Buy
JP Morgan
Overweight
TD Cowen
Buy
Morgan Stanley
Overweight
Grade Summary
Showing Top 6 of 9
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:10.09M
Value:$1.48B
BLACKROCK INC.
Shares:6.1M
Value:$892.89M
BLACKROCK, INC.
Shares:5.71M
Value:$835.31M
Summary
Showing Top 3 of 841

